The freeze-all strategy after IVF: which indications?

Blastocyst Cryopreservation Embryo Transfer Fertilization in Vitro Humans
Controlled ovarian stimulation Deferred embryo transfer Endometrium Freeze all In-vitro fertilization

Journal

Reproductive biomedicine online
ISSN: 1472-6491
Titre abrégé: Reprod Biomed Online
Pays: Netherlands
ID NLM: 101122473

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 16 06 2020
revised: 09 10 2020
accepted: 18 11 2020
pubmed: 2 1 2021
medline: 30 11 2021
entrez: 1 1 2021
Statut: ppublish

Résumé

The freeze-all strategy is gaining popularity worldwide as an alternative to the conventional fresh embryo transfer. It consists of cryopreservation of the entire embryo cohort and the embryo transfer in a subsequent cycle that takes place separately from ovarian stimulation. The freeze-all strategy was initially a 'rescue' strategy for women at high risk of ovarian hyperstimulation syndrome; however, this approach has been extended to other indications as a scheduled strategy to improve implantation rates. This assumes that ovarian stimulation can alter endometrial receptivity in fresh cycles owing to the effect of supraphysiological levels of steroids on endometrial maturation. The procedure, however, has not been associated with increased live birth rates in all infertile couples, and concerns have been raised about the occurrence of several adverse perinatal outcomes. It is, therefore, crucial to identify in which subgroups of patients a freeze-all strategy could be beneficial. The aim of this review is to summarize current scientific research in this field to highlight potential indications for this strategy and to guide clinicians in their daily practice.

Identifiants

DOI: 10.1016/j.rbmo.2020.11.013 PMID: 33384269
pubmed: 33384269
pii: S1472-6483(20)30629-5
doi: 10.1016/j.rbmo.2020.11.013
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

529-545

Informations de copyright

Copyright © 2020 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Auteurs

Mathilde Bourdon (M)

Université de Paris, Faculté de Médecine, Paris, France; Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital universitaire Paris Centre (HUPC), Paris, France; Department of Gynaecology Obstetrics and Reproductive Medicine, Centre Hospitalier Universitaire (CHU) Cochin, Paris, France, 123 Boulevard de Port-Royal 75679 Paris 14, France; Department 3I 'Infection, Immunité et inflammation', Institut Cochin, INSERM U1016, Paris, France.

Chloé Maignien (C)

Université de Paris, Faculté de Médecine, Paris, France; Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital universitaire Paris Centre (HUPC), Paris, France; Department of Gynaecology Obstetrics and Reproductive Medicine, Centre Hospitalier Universitaire (CHU) Cochin, Paris, France, 123 Boulevard de Port-Royal 75679 Paris 14, France.

Khaled Pocate-Cheriet (K)

Université de Paris, Faculté de Médecine, Paris, France; Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital universitaire Paris Centre (HUPC), Paris, France; Department of Gynaecology Obstetrics and Reproductive Medicine, Centre Hospitalier Universitaire (CHU) Cochin, Paris, France, 123 Boulevard de Port-Royal 75679 Paris 14, France; Department 3I 'Infection, Immunité et inflammation', Institut Cochin, INSERM U1016, Paris, France; Department of histology and Reproductive biology, Centre Hospitalier Universitaire (CHU) Cochin, Paris, France.

Geneviève Plu Bureau (G)

Université de Paris, Faculté de Médecine, Paris, France; Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital universitaire Paris Centre (HUPC), Paris, France; Department of Gynaecology Obstetrics and Reproductive Medicine, Centre Hospitalier Universitaire (CHU) Cochin, Paris, France, 123 Boulevard de Port-Royal 75679 Paris 14, France; Equipe EPOPE, INSERM U1153, Paris, France.

Louis Marcellin (L)

Université de Paris, Faculté de Médecine, Paris, France; Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital universitaire Paris Centre (HUPC), Paris, France; Department of Gynaecology Obstetrics and Reproductive Medicine, Centre Hospitalier Universitaire (CHU) Cochin, Paris, France, 123 Boulevard de Port-Royal 75679 Paris 14, France; Department 3I 'Infection, Immunité et inflammation', Institut Cochin, INSERM U1016, Paris, France.

Catherine Patrat (C)

Université de Paris, Faculté de Médecine, Paris, France; Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital universitaire Paris Centre (HUPC), Paris, France; Department of histology and Reproductive biology, Centre Hospitalier Universitaire (CHU) Cochin, Paris, France; Department 'Développement, Reproduction, cancer', Institut Cochin, INSERM U1016, Paris, France.

Charles Chapron (C)

Université de Paris, Faculté de Médecine, Paris, France; Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital universitaire Paris Centre (HUPC), Paris, France; Department of Gynaecology Obstetrics and Reproductive Medicine, Centre Hospitalier Universitaire (CHU) Cochin, Paris, France, 123 Boulevard de Port-Royal 75679 Paris 14, France; Equipe EPOPE, INSERM U1153, Paris, France.

Pietro Santulli (P)

Université de Paris, Faculté de Médecine, Paris, France; Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital universitaire Paris Centre (HUPC), Paris, France; Department of Gynaecology Obstetrics and Reproductive Medicine, Centre Hospitalier Universitaire (CHU) Cochin, Paris, France, 123 Boulevard de Port-Royal 75679 Paris 14, France; Department 3I 'Infection, Immunité et inflammation', Institut Cochin, INSERM U1016, Paris, France. Electronic address: pietro.santulli@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Structures de l'embryon › Embryon de mammifère › Blastocyste › The freeze-all strategy after IVF: which indications?
questionsmedicales.fr › Techniques d'investigation › Conservation biologique › Cryoconservation › The freeze-all strategy after IVF: which indications?
questionsmedicales.fr › Techniques d'investigation › Techniques de reproduction › Techniques de reproduction assistée › Transfert d'embryon › The freeze-all strategy after IVF: which indications?
questionsmedicales.fr › Techniques d'investigation › Techniques de reproduction › Techniques de reproduction assistée › Fécondation in vitro › The freeze-all strategy after IVF: which indications?
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › The freeze-all strategy after IVF: which indications?